ArticleBreast cancer research : BCR2025

Prediction of pathological complete response after neoadjuvant chemotherapy for HER2-negative breast cancer patients with routine immunohistochemical markers.

Lothar Häberle et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.